ProfLeonie Young

Professor

Department of Surgery

  • Professor
    Department of Surgery
  • 01 4028576 (Work)
  • RCSI, Surgery, York House - York Street, Dublin 2

RESEARCH OVERVIEW

Translational studies from our group and others have provided significant evidence of a significant role for Steroid Receptor Coactivator (SRC) proteins in the development of resistance to endocrine therapy in breast cancer. Subsequently, we have created a tissue microarray (TMA) of 500 patients with known clinical parameters which we will utilise to assess expression of ER-alpha, ER-beta, SRC-1 and SRC-3 in paraffin-embedded breast cancer tissue by immunohistochemistry. Intracellular localisation of the nuclear receptors and co-activators will be assessed by immunofluorescence and the sections examined by confocal microscopy. We then propose to undertake in-situ fluorescence resonance energy transfer (FRET) experiments to elucidate interactions between ER isoforms and co-activator proteins in breast cancer tissue. Nuclear receptor-co-activator interactions will be correlated with clinicopathological parameters and disease outcome.Uniquely, this study will utilise primary cell cultures derived from patient tumours, thus providing samples not readily available in most molecular model systems. 3D ascini will be cultured ex vivo from primary cells derived from patient tumours to enable the investigation of nuclear receptor and co-activator expression in ductal structures. Spatial trans-localisation of nuclear receptors and co-activator proteins in resultant epithelial ducts in response to endocrine treatments will be determined by confocal live-cell imaging systems.

GRANTS

  • FUNDED PROJECT
    Student Selected Projects (SSP) 2027
    RCSI1 Oct 2026 - 30 Sep 2027
  • FUNDED PROJECT
    Student Selected Projects (SSP) 2026
    RCSI9 Feb 2026 - 21 Dec 2026
  • FUNDED PROJECT
    HER2-CNS Surveillance
    Breast Cancer Ireland1 Oct 2025 - 30 Sep 2027
  • FUNDED PROJECT
    Precision Oncology Ireland-2 (POI2)
    Research Ireland1 Oct 2025 - 30 Sep 2030
  • FUNDED PROJECT
    Research Ireland - Precision Oncology Ireland 2 (POI2) Co-Fund
    RCSI1 Oct 2025 - 30 Sep 2031
  • FUNDED PROJECT
    Targeted treatment resistance in metastatic breast cancer - Phase 2
    Breast Cancer Ireland1 Oct 2025 - 30 Sep 2030
  • FUNDED PROJECT
    CAMBRIA-2 Consultancy Funds
    Industry – Consultancy-Economic Activity25 Jun 2025 - 24 Jun 2027
  • FUNDED PROJECT
    ARC Hub for Therapeutic Innovation
    Science Foundation Ireland (SFI)1 Jan 2025 - 31 Dec 2029
  • FUNDED PROJECT
    Research Ireland (formerly IRC) 2025 Supplementary Stipend
    Research Ireland1 Jan 2025 - 31 Dec 2025
  • FUNDED PROJECT
    Research Ireland (formerly SFI) 2025 Supplementary Stipend
    Research Ireland1 Jan 2025 - 31 Dec 2025
  • FUNDED PROJECT
    Acquired genomic adaptations as targeted therapeutic strategies for metastatic breast cancer: A breakthrough programme for brain metastasis (GeTTMet)
    Breast Cancer Ireland1 Aug 2024 - 31 Jul 2028
  • FUNDED PROJECT
    Acquired genomic adaptations as targeted therapeutic strategies for metastatic breast cancer: A breakthrough programme for brain metastasis (GeTTMet)
    Breast Cancer Ireland1 Aug 2024 - 31 Jul 2028
  • FUNDED PROJECT
    Acquired genomic adaptations as targeted therapeutic strategies for metastatic breast cancer: A breakthrough programme for brain metastasis (GeTTMet)
    Breast Cancer Ireland1 Aug 2024 - 31 Jul 2028
  • FUNDED PROJECT
    Acquired genomic adaptations as targeted therapeutic strategies for metastatic breast cancer: A breakthrough programme for brain metastasis (GeTTMet)
    Science Foundation Ireland (SFI)1 Aug 2024 - 31 Jul 2028
  • FUNDED PROJECT
    Acquired genomic adaptations as targeted therapeutic strategies for metastatic breast cancer: A breakthrough programme for brain metastasis (GeTTMet)
    Science Foundation Ireland (SFI)1 Aug 2024 - 31 Jul 2028
  • FUNDED PROJECT
    Acquired genomic adaptations as targeted therapeutic strategies for metastatic breast cancer: A breakthrough programme for brain metastasis (GeTTMet)
    Science Foundation Ireland (SFI)1 Aug 2024 - 31 Jul 2028
  • FUNDED PROJECT
    Acquired genomic adaptations as targeted therapeutic strategies for metastatic breast cancer: A breakthrough programme for brain metastasis (GeTTMet)
    Science Foundation Ireland (SFI)1 Aug 2024 - 31 Jul 2028
  • FUNDED PROJECT
    Acquired genomic adaptations as targeted therapeutic strategies for metastatic breast cancer: A breakthrough programme for brain metastasis (GeTTMet)
    Industry – Co-Funded Collaborative Research – RCSI owns IP1 Aug 2024 - 31 Jul 2028
  • FUNDED PROJECT
    Student Selected Projects (SSP) 2024
    RCSI29 Apr 2024 - 28 Apr 2025
  • FUNDED PROJECT
    Avril Watters Breast Cancer Ireland Scholarship
    Breast Cancer Ireland1 Jan 2024 - 31 Dec 2026
  • FUNDED PROJECT
    SFI PhD 2024 Additional Stipend Allowance
    Science Foundation Ireland (SFI)1 Jan 2024 - 31 Dec 2024
  • FUNDED PROJECT
    Blue Organoids for Treatment Selection (BOTS)
    European Union / EU31 Dec 2023 - 30 Dec 2026
  • FUNDED PROJECT
    A randomised interventional study to examine whether communication of expected timeframes between points of the cancer pathway has an impact on patient reported experience and overall outcomes
    Irish Research Council IRC1 Sep 2023 - 31 Aug 2026
    People funded by this grant:
    • Claire N
  • FUNDED PROJECT
    Collaborative Initiative 2023/24
    RCSI1 Sep 2023 - 31 Aug 2025
  • FUNDED PROJECT
    Integration of aberrant gene expression and spatial genomics to identify new druggable targets to treat breast cancer brain metastasis
    Irish Research Council IRC1 Sep 2023 - 31 Aug 2026